Explore our tests
Discover the right genetic test for your patient in our complete list of tests and panels.
Showing 10 out of 402 tests
Non-Immune Hydrops Fetalis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12661
2 - 3 weeks (7 - 16 days STAT)•Test 12661149 Genes
Nonsyndromic Congenital Heart Disease Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 13097
2 - 3 weeks (6 - 12 days STAT)•Test 1309744 Genes
Noonan Spectrum Disorders/RASopathies Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (7 - 16 days STAT)•Test 10327
2 - 3 weeks (7 - 16 days STAT)•Test 1032723 Genes
Oculocutaneous Albinism and Hypopigmentation Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (7 - 16 days STAT)•Test 10313
2 - 3 weeks (7 - 16 days STAT)•Test 1031331 Genes
Oculocutaneous Albinism Type 2 (OCAII) via the OCA2 Known Intragenic Gross Deletion
Targeted PCR2 - 3 weeks (8 - 10 days STAT)•Test 3738
2 - 3 weeks (8 - 10 days STAT)•Test 37381 Gene
Oculopharyngeal Muscular Dystrophy via the PABPN1 (GCN) Repeat Expansion
Expansion Assay1 - 2 weeks (6 - 10 days STAT)•Test 6058
1 - 2 weeks (6 - 10 days STAT)•Test 60581 Gene
Optic Atrophy and Hereditary Spastic Paraplegia via the SPG7 Gene
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 11707
2 - 3 weeks (6 - 12 days STAT)•Test 117071 Gene
Optic Atrophy and Neuropathy Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 10331
2 - 3 weeks (6 - 12 days STAT)•Test 1033170 Genes
Organic Aciduria Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 10391
2 - 3 weeks (6 - 12 days STAT)•Test 1039141 Genes
Ornithine Transcarbamylase Deficiency via the OTC Gene
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (7 - 16 days STAT)•Test 9723
2 - 3 weeks (7 - 16 days STAT)•Test 97231 Gene